Columbia Financial, Inc.’s CLBK shares appreciated 5.1% on Friday following the announcement of a new share-repurchase plan. The board of directors has approved the repurchase of about 5 million shares.
The shares that have been authorized to be repurchased under the program represent 4.3% of the company’s issued shares and outstanding common stock. The plan, which begins on Sep 15, 2020, has received a notice of non-objection from the Federal Reserve Bank of Philadelphia.
The latest plan comes a few months after Columbia Financial completed its earlier share-buyback program. The plan, the company’s first, was announced last June and expanded in December 2019. The program, completed on Apr 23, 2020, involved the repurchase of about 7 million shares.
Thomas J. Kemly, president and CEO of the company, said, “I am happy to announce our new repurchase program. The company completed its last repurchase program during the height of the pandemic in our market area and elected to pause its capital management initiatives to evaluate the pandemic’s impact on the company’s financial position, while focusing on how best to support our customers, employees and the community.”
As of Jun 30, Columbia Financial had a total debt of $1.12 billion, significantly higher than the cash and cash equivalents balance of $86.04 million. Nevertheless, its total debt to total capital of 52.05% at the end of the second quarter improved sequentially and is lower than the industry average of 61.04%. Moreover, the company’s times-interest-earned ratio of 3.6 at the end of the June-end quarter improved sequentially. Given the earnings strength and no dividend payments, it will likely be able to sustain the current level of capital-deployment activities.
Over the past year, shares of Columbia Financial have depreciated 29% compared with the 9.7% decline of the industry it belongs to.
Currently, Columbia Financial carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
A few other finance stocks that have announced new/additional buyback authorizations this year include MVB Financial MVBF, PennyMac Financial PFSI and Jefferies Financial JEF.
MVB Financial announced repurchase up to $5 million worth of outstanding common stock. PennyMac Financial repurchased 6.9 million shares at a price of $34 per share from The BlackRock Foundation, the charitable arm of BlackRock, Inc. in June. Jefferies Financial increased its buyback program to $250 million in January, while in March the company authorized an additional share repurchase of $100 million.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Click to get this free report
Jefferies Financial Group Inc. (JEF): Free Stock Analysis Report
PennyMac Financial Services, Inc. (PFSI): Free Stock Analysis Report
Mvb Financial Corp. (MVBF): Free Stock Analysis Report
COLUMBIA FINL (CLBK): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.